欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4735/001
药品名称Azacitidine Sandoz 25 mg/ml, powder for suspension for injection
活性成分
    • azacitidine 25.0 mg/ml
剂型Suspension for suspension for injection
上市许可持有人Sandoz B.V.
参考成员国 - 产品名称Netherlands (NL)
Azacitidine Sandoz 25 mg/ml, poeder voor suspensie voor injectie
互认成员国 - 产品名称
    • Germany (DE)
      Azacitidin HEXAL 25 mg/ml Pulver zur Herstellung einer Injektionssuspension
    • Denmark (DK)
    • Belgium (BE)
      Azacitidin Sandoz 25 mg/ml poeder voor suspensie voor injectie
    • Iceland (IS)
      Azacitadine Sandoz
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Azacitidin Sandoz 25 mg/ml - Pulver zur Herstellung einer Injektionssuspension
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
      Azacitidine Sandoz
    • Finland (FI)
    • Poland (PL)
      Azacitifine Sandoz
    • Hungary (HU)
    • Bulgaria (BG)
      AzacitidineSandoz
    • Czechia (CZ)
      Azaticidine Sandoz
    • Romania (RO)
    • Slovakia (SK)
      Azacitidine Sandoz 25 mg/ml prášok na injekčnú suspenziu
    • Slovenia (SI)
      Azacitidin Sandoz 25 mg/ml prašek za suspenzijo za injiciranje
    • Croatia (HR)
    • Cyprus (CY)
      Azacitidine/Sandoz 25 mg/ml κόνις για ενέσιμο εναιώρημα
    • Malta (MT)
许可日期2020/04/24
最近更新日期2024/04/29
药物ATC编码
    • L01BC07 azacitidine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Multiple (Copy) Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase